Its my World of Blogging

WHAT IS CANCER? We will discuss in brief about cancer. Cancer is a large, heterogeneous class of diseases in which a group of cells display uncontrolled growth, invasion that intrudes upon and destroys adjacent tissues, and often metastasizes, wherein the tumor cells spread to other locations in the body via the lymphatic system or through the bloodstream. An Ottawa-based research team has developed a virus that is showing promise as a new way of attacking and shrinking cancer tumours while leaving healthy tissue alone. It's early days in the still-experimental field of therapeutic cancer viruses, called oncolytic viruses. But this new study from researchers from the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa advances the field a little further by showing that the virus is safe in most patients. For the study, researchers recruited 23 advanced ca...

Marketing Research Proposal Executive summary -- the proposal should begin with a summary of the major points from each of the other sections, presenting an overview of the entire proposal Background -- the background of the problem, including the environmental context, should be discussed Problem definition/objectives of the research -- normally a statement of the problem, including the specific components, should be presented. If this statement has not been developed (in the case of problem identification research), the objectives of the marketing research project should be clearly specified approach to the problem -- at a minimum, a review of the relevant academic and trade literature should be presented, along with some kind of analytical model. If research questions and hypotheses have been identified, then he should be included in the proposal Research design -- the research designed adopted, whether exploratory, descriptive, or casual, should be specified...

Nissan Motor India has unveiled a mid-size sedan Sunny, which is priced in the range of Rs 5.78 lakh - Rs 7.68 lakh. After the Nissan Micra, this is the auto manufacturer's second locally-made mass-market product, which it aims to give higher volumes in the upcoming festive season. Moreover, the prices are uniform across India, though the sedan will be available in the initial stage only as a petrol model. The bookings of Nissan Sunny will commence from today and the deliveries will start from October 3. The Nissan Sunny will be giving strong competition to other vehicles like Maruti Suzuki Swift Dzire, Toyota Etios and Volkswagen Vento.

Car-maker SkodaAuto India has launched a new edition of its premium sedan Laura RS in India, priced at Rs 15.49 lakh (ex-showroom, Delhi).

Renault to commence phase II of India market strategy, plans new products to launch next year French commercial vehicle manufacturer Renault, is all to commence the second phase of the India market strategy after the successful first phase completion this month with the establishment of its Fluence sedan and Koleos SUV brands in the premium car segment. As per the business strategy for the second phase, the company may roll out an all new small car in the first few months of 2012. The new launches will be based on the same V-platform that supports the Nissan Micra and Sunny. The new product are designed under the consideration of Indian market and will compete with Maruti Suzuki's Swift and the Hyundai i20. Moreover, in mid-2012 the company will launch its fourth product the SUV Duster which will compete with Mahindra's Scorpio and the Tata Safari. As per the dealer of the company, the fifth product of the comp...

Mylan's Indian arm Matrix Labs gets tentative approval from USFDA for AIDS tablets  Matrix Laboratories, the Indian arm of drugmaker Mylan Inc, has received the tentative approval from the US Food and Drug Administration (USFDA) to market its generic Lamivudine, Tenofovir Disoproxil Fumarate tablets, used for treatment of AIDS/HIV. Under the granted approval, Matrix Laboratories is permitted to market Lamivudine, Tenofovir Disoproxil Fumarate tablets in the strengths of 300 mg co-packaged with Nevirapine tablets in the strength of 200 mg. Mr Heather Bresch, Mylan President, said, “The approval of Lamivudine, Tenofovir Disoproxil Fumarate tablets co-packaged with Nevirapine tablets is an important product developed by Matrix for the treatment of HIV/AIDS.” Mr Robert J Coury, Mylan Vice Chairman and CEO, said, “This product approval is yet another important step in providing access to a range of critical HIV m...

Bayer Healthcare to acquire Pathway Medical Technologies